Press Release 2017-11-14

Press Release 2017-11-14

For Immediate Release: November 14, 2017

Minimus Spine signs first European Distribution Agreement with MOSS S.p.A. and completes initial stocking order.

Minimus Spine Inc, a medical device manufacturer with a patented medical grade ozone injection system intended for spinal disc herniations, branded as “Triojection”, announced today that it has received its first commercial order and realized its first revenue. Triojection systems are being shipped to its initial European distributor, MOSS S.p.A. in Italy, who has been granted exclusive distribution rights for Italy, Germany, Switzerland and the UK.

Minimus Spine’s CEO and President, David M. Hooper PhD, said “We are happy to be working with Franco Papa and his company MOSS. MOSS has a range of novel products tailored for the interventional radiology community and this provides us with key distribution channels in Europe. Our plan is to introduce Triojection to select accounts over the next few months and expand the launch with additional distributors next year.”

Franco Papa, President and CEO of MOSS, added “We are pleased to be partnering with Minimus in their European commercialization effort. Over the past months, we introduced the Triojection concept to leading physicians at selected European reference centres with the aim of significantly promoting a successful market penetration.”

Dr. Josip Buric, an Italian neurosurgeon and advisor to Minimus Spine, remarked “Triojection brings a greater level of safety and consistency to performing intradiscal ozone injections. It brings standardization to the entire procedure and raises the current state of the art. It is a less-invasive, lower cost alternative to surgery that reduces the need for pain medication, including opioids, for disc herniation pathology.”

Jeff Binder, a member of Minimus Spine’s board of directors, added “David has done a great job seeing us to this milestone. I see physicians and patients gravitating to less invasive spine technologies like Triojection. The demand is undeniable.”

About Minimus Spine Inc.: Established in 2006, Minimus Spine is a privately held medical device company dedicated to developing the Triojection technology the non-surgical treatment of herniated discs. Minimus Spine’s CEO and team largely stem from Spinal Concepts, another spinal startup that was sold to Abbott for $170M. The company is positioning itself for sale to one of several medical device strategics after achieving successful European adoption of its product. Minimus Spine maintains its headquarters in Austin, TX. For more information on Minimus Spine, please visit or email

About MOSS S.p.A.: Established in 2000, MOSS is the distributor of a collection of innovative medical device products. MOSS is organized into three main areas including distribution, technical service and manufacturing. The company is certified to ISO 13485 and ISO 9001. MOSS maintains its headquarters in Lesa Italy. For more information on MOSS, please visit or call at +39 0322 772032.